These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 32115322)

  • 1. Setting a research agenda for vascular Ehlers-Danlos syndrome using a patient and stakeholder engagement model.
    Sage L; Russo ML; Byers PH; Demasi J; Morris SA; Puryear LN; Fulton DS; Shalhub S;
    J Vasc Surg; 2020 Oct; 72(4):1436-1444.e2. PubMed ID: 32115322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the Information Sources and Interest in Research Collaboration Among Individuals with Vascular Ehlers-Danlos Syndrome.
    Shalhub S; Sage L; Demasi J; Wallace SE; Fulton DS; Bloom L; Driessnack M; Byers PH;
    Ann Vasc Surg; 2020 Jan; 62():326-334. PubMed ID: 31449940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
    Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
    J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-centered prioritization of bladder cancer research.
    Smith AB; Chisolm S; Deal A; Spangler A; Quale DZ; Bangs R; Jones JM; Gore JL
    Cancer; 2018 Aug; 124(15):3136-3144. PubMed ID: 29727033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a Patient- and Family-Centered Research Agenda for Hospital Medicine: The Improving Hospital Outcomes through Patient Engagement (i-HOPE) Study.
    Harrison JD; Archuleta M; Avitia E; Banta J; Benn J; Burden M; Chopra V; Coker R; Eid S; Fang MC; Fletcher K; Hagan J; Jaranilla J; Mullick M; Nyenpan C; Silva L; Wurst M; Ziegler G; Leykum L
    J Hosp Med; 2020 Jun; 15(6):331-337. PubMed ID: 32490806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular Ehlers-Danlos Syndrome With a Novel Missense COL3A1 Mutation Present With Pulmonary Complications and Iliac Arterial Dissection.
    Gu G; Yang H; Cui L; Fu Y; Li F; Zhou Z; Zheng Y
    Vasc Endovascular Surg; 2018 Feb; 52(2):138-142. PubMed ID: 29216800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lung cancer research agenda that reflects the diverse perspectives of community stakeholders: process and outcomes of the SEED method.
    Rafie CL; Zimmerman EB; Moser DE; Cook S; Zarghami F
    Res Involv Engagem; 2019; 5():3. PubMed ID: 30656063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers-Danlos syndrome.
    Shalhub S; Neptune E; Sanchez DE; Dua A; Arellano N; McDonnell NB; Milewicz DM
    Am J Med Genet A; 2019 May; 179(5):797-802. PubMed ID: 30793832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network.
    Boyer AP; Fair AM; Joosten YA; Dolor RJ; Williams NA; Sherden L; Stallings S; Smoot DT; Wilkins CH
    Med Care; 2018 Oct; 56 Suppl 10 Suppl 1(10 Suppl 1):S22-S26. PubMed ID: 30074947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiprolol Treatment in Patients with Vascular Ehlers-Danlos Syndrome.
    Baderkhan H; Wanhainen A; Stenborg A; Stattin EL; Björck M
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):326-331. PubMed ID: 33223285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six uneventful pregnancy outcomes in an extended vascular Ehlers-Danlos syndrome family.
    Baas AF; Spiering W; Moll FL; Page-Christiaens L; Beenakkers IC; Dooijes D; Vonken EP; van der Smagt JJ; Knoers NV; Koenen SV; van Herwaarden JA; Sieswerda GT
    Am J Med Genet A; 2017 Feb; 173(2):519-523. PubMed ID: 28102592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing an obesity research agenda with British Pakistani women living in deprived areas with involvement from multisectoral stakeholders: Research priority setting with a seldom heard group.
    Iqbal H; West J; McEachan RRC; Haith-Cooper M
    Health Expect; 2022 Aug; 25(4):1619-1632. PubMed ID: 35484840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome.
    Morissette R; Schoenhoff F; Xu Z; Shilane DA; Griswold BF; Chen W; Yang J; Zhu J; Fert-Bober J; Sloper L; Lehman J; Commins N; Van Eyk JE; McDonnell NB
    Circ Cardiovasc Genet; 2014 Feb; 7(1):80-8. PubMed ID: 24399159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engaging Stakeholders to Develop a Patient-centered Research Agenda: Lessons Learned From the Research Action for Health Network (REACHnet).
    Haynes SC; Rudov L; Nauman E; Hendryx L; Angove RSM; Carton T
    Med Care; 2018 Oct; 56 Suppl 10 Suppl 1(10 Suppl 1):S27-S32. PubMed ID: 30074948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying and prioritising systematic review topics with public health stakeholders: A protocol for a modified Delphi study in Switzerland to inform future research agendas.
    Hoekstra D; Mütsch M; Kien C; Gerhardus A; Lhachimi SK
    BMJ Open; 2017 Aug; 7(8):e015500. PubMed ID: 28780546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum stress and collagenous formation anomalies in vascular-type Ehlers-Danlos syndrome via electron microscopy.
    Ishikawa S; Kosho T; Kaminaga T; Miyamoto M; Hamasaki Y; Yoshihara S; Hayashi S; Igawa K
    J Dermatol; 2021 Apr; 48(4):481-485. PubMed ID: 33523542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective stakeholder engagement: design and implementation of a clinical trial (SWOG S1415CD) to improve cancer care.
    Barger S; Sullivan SD; Bell-Brown A; Bott B; Ciccarella AM; Golenski J; Gorman M; Johnson J; Kreizenbeck K; Kurttila F; Mason G; Myers J; Seigel C; Wade JL; Walia G; Watabayashi K; Lyman GH; Ramsey SD
    BMC Med Res Methodol; 2019 Jun; 19(1):119. PubMed ID: 31185918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular Ehlers-Danlos Syndrome: Literature review and surgical management of intracranial vascular complications.
    Olubajo F; Kaliaperumal C; Choudhari KA
    Clin Neurol Neurosurg; 2020 Jun; 193():105775. PubMed ID: 32197145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular Ehlers-Danlos syndrome: pathophysiology, diagnosis, and prevention and treatment of its complications.
    Beridze N; Frishman WH
    Cardiol Rev; 2012; 20(1):4-7. PubMed ID: 22143279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Frameshift COL3A1 Variant in Vascular Ehlers-Danlos Syndrome.
    Olson SL; Murray ML; Skeik N
    Ann Vasc Surg; 2019 Nov; 61():472.e9-472.e13. PubMed ID: 31394236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.